2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Pseudomyxoma Peritonei: new trials by email Literature Review of Pseudomyxoma Peritonei trials Research Report on Pseudomyxoma Peritonei
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei Bromelain, Acetylcysteine, Interventional radiology insertion of drain - Pseudomyxoma Peritonei, Peritoneal Cancer | Phase 2 | Unknown | Mucpharm Pty Ltd | 62 | 2022-05-01 | 2022-03-15 |
| Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients Capecitabine - Pseudomyxoma Peritonei | Phase 2 | Unknown | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 28 | 2018-12-03 | 2022-04-11 |
Adenocarcinoma, Mucinous (1) · Neoplasms, Cystic, Mucinous, and Serous (1)
Adenocarcinoma (2) · Carcinoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Adenocarcinoma, Mucinous (1) · Neoplasms, Cystic, Mucinous, and Serous (1)
Acetylcysteine (1) · Bromelains (1) · Capecitabine (1)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Mucpharm Pty Ltd (1)
Italy (1)
Alvaro Arjona Sanchez, MD (1) · Armando Sardi, MD (1) · Edward Levine, MD (1) · Haroon Choudry, MD (1) · Ignace de Hingh, MD (1) · Maria Di Bartolomeo, MD (1)